520 related articles for article (PubMed ID: 15712343)
1. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells.
Hoelters J; Ciccarella M; Drechsel M; Geissler C; Gülkan H; Böcker W; Schieker M; Jochum M; Neth P
J Gene Med; 2005 Jun; 7(6):718-28. PubMed ID: 15712343
[TBL] [Abstract][Full Text] [Related]
2. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of EGFP expression by siRNA in EGFP-stably expressing Huh-7 cells.
Cao M; Ren H; Pan X; Pan W; Qi ZT
J Virol Methods; 2004 Aug; 119(2):189-94. PubMed ID: 15158602
[TBL] [Abstract][Full Text] [Related]
4. A novel human artificial chromosome vector provides effective cell lineage-specific transgene expression in human mesenchymal stem cells.
Ren X; Katoh M; Hoshiya H; Kurimasa A; Inoue T; Ayabe F; Shibata K; Toguchida J; Oshimura M
Stem Cells; 2005; 23(10):1608-16. PubMed ID: 16141362
[TBL] [Abstract][Full Text] [Related]
5. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
[TBL] [Abstract][Full Text] [Related]
6. An hydrophobically modified arginine peptide vector system effectively delivers DNA into human mesenchymal stem cells and maintains transgene expression with differentiation.
Kim NY; Choi YB; Kang CI; Kim HH; Yang JM; Shin S
J Gene Med; 2010 Sep; 12(9):779-89. PubMed ID: 20821748
[TBL] [Abstract][Full Text] [Related]
7. Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA.
Kishida T; Asada H; Gojo S; Ohashi S; Shin-Ya M; Yasutomi K; Terauchi R; Takahashi KA; Kubo T; Imanishi J; Mazda O
J Gene Med; 2004 Jan; 6(1):105-10. PubMed ID: 14716682
[TBL] [Abstract][Full Text] [Related]
8. An intracellular delivery method for siRNA by an arginine-rich peptide.
Wang YH; Hou YW; Lee HJ
J Biochem Biophys Methods; 2007 Jun; 70(4):579-86. PubMed ID: 17320189
[TBL] [Abstract][Full Text] [Related]
9. A universal transgene silencing approach in baculovirus-insect cell system.
Salem TZ; Maruniak JE
J Virol Methods; 2007 Oct; 145(1):1-8. PubMed ID: 17548118
[TBL] [Abstract][Full Text] [Related]
10. Downregulation enhanced green fluorescence protein gene expression by RNA interference in mammalian cells.
Zhang M; Bai CX; Zhang X; Chen J; Mao L; Gao L
RNA Biol; 2004 May; 1(1):74-7. PubMed ID: 17194936
[TBL] [Abstract][Full Text] [Related]
11. Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells.
Aluigi M; Fogli M; Curti A; Isidori A; Gruppioni E; Chiodoni C; Colombo MP; Versura P; D'Errico-Grigioni A; Ferri E; Baccarani M; Lemoli RM
Stem Cells; 2006 Feb; 24(2):454-61. PubMed ID: 16099993
[TBL] [Abstract][Full Text] [Related]
12. Efficient characterisation of human cell-bioceramic interactions in vitro and in vivo by using enhanced GFP-labelled mesenchymal stem cells.
Xia Z; Ye H; Locklin RM; Ferguson DJ; Cui Z; Triffitt JT
Biomaterials; 2005 Oct; 26(29):5790-800. PubMed ID: 15882901
[TBL] [Abstract][Full Text] [Related]
13. RNA interference (RNAi) in hematology.
Scherr M; Steinmann D; Eder M
Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
[TBL] [Abstract][Full Text] [Related]
14. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis.
Khoury M; Courties G; Fabre S; Bouffi C; Seemayer CA; Vervoordeldonk MJ; Tak PP; Jorgensen C; Apparailly F
Arthritis Rheum; 2010 Mar; 62(3):765-70. PubMed ID: 20187132
[TBL] [Abstract][Full Text] [Related]
16. An efficient transfection method for mouse embryonic stem cells.
Ko BS; Chang TC; Shyue SK; Chen YC; Liou JY
Gene Ther; 2009 Jan; 16(1):154-8. PubMed ID: 18668145
[TBL] [Abstract][Full Text] [Related]
17. Vector-based in vivo RNA interference: dose- and time-dependent suppression of transgene expression.
Kobayashi N; Matsui Y; Kawase A; Hirata K; Miyagishi M; Taira K; Nishikawa M; Takakura Y
J Pharmacol Exp Ther; 2004 Feb; 308(2):688-93. PubMed ID: 14610223
[TBL] [Abstract][Full Text] [Related]
18. Quantitative polymerase chain reaction as a reliable method to determine functional lentiviral titer after ex vivo gene transfer in human mesenchymal stem cells.
Böcker W; Rossmann O; Docheva D; Malterer G; Mutschler W; Schieker M
J Gene Med; 2007 Jul; 9(7):585-95. PubMed ID: 17510916
[TBL] [Abstract][Full Text] [Related]
19. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
20. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
